Abstract:This paper reviews the body of evidence that major depression is accompanied by a decreased antioxidant status and by induction of oxidative and nitrosative (IO&NS) pathways. Major depression is characterized by significantly lower plasma concentrations of a number of key antioxidants, such as vitamin E, zinc and coenzyme Q10, and a lowered total antioxidant status. Lowered antioxidant enzyme activity, e.g. glutathione peroxidase (GPX), is another hallmark of depression. The abovementioned lowered antioxidant capacity may impair protection against reactive oxygen species (ROS), causing damage to fatty acids, proteins and DNA by oxidative and nitrosative stress (O&NS). Increased ROS in depression is demonstrated by increased levels of plasma peroxides and xanthine oxidase. Damage caused by O&NS is shown by increased levels of malondialdehyde (MDA), a by-product of polyunsaturated fatty acid peroxidation and arachidonic acid; and increased 8-hydroxy-2-deoxyguanosine, indicating oxidative DNA damage. There is also evidence in major depression, that O&NS may have changed inactive autoepitopes to neoantigens, which have acquired immunogenicity and serve as triggers to bypass immunological tolerance, causing (auto)immune responses. Thus, depression is accompanied by increased levels of plasma IgG antibodies against oxidized LDL; and increased IgM-mediated immune responses against membrane fatty acids, like phosphatidyl inositol (Pi); oleic, palmitic, and myristic acid; and NO modified amino-acids, e.g. NO-tyrosine, NO-tryptophan and NO-arginine; and NO-albumin. There is a significant association between depression and polymorphisms in O&NS genes, like manganese superoxide dismutase, catalase, and myeloperoxidase. Animal models of depression very consistently show lowered antioxidant defences and activated O&NS pathways in the peripheral blood and the brain. In animal models of depression, antidepressants consistently increase lowered antioxidant levels and normalize the damage caused by O&NS processes. Antioxidants, such as N-acetyl-cysteine, compounds that mimic GPX activity, and zinc exhibit antidepressive effects. This paper reviews the pathways by which lowered antioxidants and O&NS may contribute to depression, and the (neuro)degenerative processes that accompany that illness. It is concluded that aberrations in O&NS pathways are - together with the inflammatory processes - key components of depression. All in all, the results suggest that depression belongs to the spectrum of (neuro)degenerative disorders.

Lower Whole Blood Glutathione Peroxidase (gpx) Activity in Depression, but Not in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Another Pathway That May Be Associated with Coronary Artery Disease and Neuroprogression in Depression

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease

Increased 8-Hydroxy-deoxyguanosine, A Marker of Oxidative Damage to Dna, in Major Depression and Myalgic Encephalomyelitis Chronic Fatigue Syndrome

Increased Plasma Peroxides As A Marker of Oxidative Stress in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Me/cfs)

Lower Plasma Coenzyme Q10 in Depression: A Marker for Treatment Resistance and Chronic Fatigue in Depression and A Risk Factor to Cardiovascular Disorder in That Illness

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Quantification of glutathione and its associated spontaneous neuronal activity in major depressive disorder and obsessive-compulsive disorder

Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.

Lymphocyte levels of redox-sensitive transcription factors and antioxidative enzymes as indicators of pro-oxidative state in depressive patients

An IgM-mediated Immune Response Directed Against Nitro-Bovine Serum Albumin (Nitro-Bsa) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That Nitrosative Stress is Another Factor Underpinning the Comorbidity Between Major Depression and CFS.

IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression

Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses

Lower Serum Vitamin E Concentrations in Major Depression. Another Marker of Lowered Antioxidant Defenses in That Illness.

IgM-mediated Autoimmune Responses Directed Against Multiple Neoepitopes in Depression: New Pathways That Underpin the Inflammatory and Neuroprogressive Pathophysiology

An intriguing and hitherto unexplained co-occurrence: Depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways

Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways

A Meta-Analysis of Oxidative Stress Markers in Depression

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression.

Mitochondrial dysfunctions in Myalgic Encephalomyelitis / chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways

The Glutathione System: A New Drug Target in Neuroimmune Disorders

Attenuation of Autoimmune Responses to Oxidative Specific Epitopes, but Not Nitroso-Adducts, is Associated with a Better Clinical Outcome in Myalgic Encephalomyelitis/chronic Fatigue Syndrome.